Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 3353-3360, June 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gruss, H.-J.
Right arrow Articles by Herrmann, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gruss, H.-J.
Right arrow Articles by Herrmann, F.

Expression of Cytokine Genes, Cytokine Receptor Genes, and Transcription Factors in Cultured Hodgkin and Reed-Sternberg Cells1

Hans-Jürgen Gruss, Marion A. Brach, Hans-Günter Drexler, Renate Bonifer, Roland H. Mertelsmann and Friedhelm Herrmann2

Department of Internal Medicine I, University of Freiburg Medical Center, Freiburg [H-J. G., M. A. B., R. B., R. H. M., F. H.], and German Collection of Microorganisms and Cell Cultures [H-G. D.], Braunschweig, Germany

In the present study, we show by Northern blot analysis and enzyme linked immunosorbent assay that the Hodgkin's disease (HD)-derived cell lines HDLM-2 and KM-H2 express a variety of cytokine genes either constitutively or upon induction with phorbol ester 12-O-tetrade-canoylphorbol-13-acetate. Cytokine genes expressed by HD-derived lines include granulocyte-macrophage colony-stimulating factor (CSF), macrophage-CSF, interleukin (IL)-1-{alpha}, IL-3, IL-5, IL-6, IL-8, leukemia inhibitory factor, tumor necrosis factor-{alpha}, tumor necrosis factor-ß, and transforming growth factor-ß, while transcripts and the corresponding proteins for granulocyte-CSF, IL-1-ß, IL-2, IL-4, IL-7, IL-10, and the JE/macrophage chemoattractant and activating factor gene were not detectable in cytoplasmic RNA and culture supernatants obtained from both lines. In addition, IL-2 receptor (R) p55 and macrophage-CSF R (c-fms) genes were expressed by both lines. HDLM-2, but not KM-H2 cells, exhibited the IL-6 R p80 and the IL-2 R p75 chain. Analysis of nuclear proteins that bind to oligonucleotides containing the consensus sequences of the transcription factors activation protein 1, nuclear factor (NF) {kappa}B, and NFAT 1 revealed a pattern for HD lines resembling that of activated T-cells: HDLM-2 and KM-H2 cells constitutively expressed NF binding to the NF of activated T-cells (type 1), previously described to be T-cell specific. In addition, NF {kappa}B-binding proteins obtained from both lines showed, in electrophoretic mobility shift assays, the same migration pattern as T-cell-derived proteins but differed from monocyte- and B-cell-derived proteins. UV cross-linking experiments confirmed that NF {kappa}B-binding proteins of Mr 85,000, 75,000, and 50,000/55,000 were detectable in nuclear extracts obtained from T-cells and both HD lines, while monocytes and B-cells displayed the Mr 50,000/55,000 and 75,000 NF {kappa}B complex only. Both HD lines also constitutively expressed transcripts for c-fos and c-jun, which are involved in heterodimeric formation of the transcription factor activation protein 1, as well as for the NF {kappa}B/KBF1 gene.

1 Supported by the Deutsche Krebshilfe.

2 To whom requests for reprints should be addressed, at Department of Internal Medicine I, University of Freiburg Medical Center, Hugstetter Str. 55, D-7800 Freiburg i.Br., Germany.

Received 12/10/91. Accepted 4/ 6/92.




This article has been cited by other articles:


Home page
BloodHome page
M. Kawakami, K. Kawakami, M. Kioi, P. Leland, and R. K. Puri
Hodgkin lymphoma therapy with interleukin-4 receptor-directed cytotoxin in an infiltrating animal model
Blood, May 1, 2005; 105(9): 3707 - 3713.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Laouar, I. N. Crispe, and R. A. Flavell
Overexpression of IL-7R{alpha} provides a competitive advantage during early T-cell development
Blood, March 15, 2004; 103(6): 1985 - 1994.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Watanabe, Y. Ogawa, K. Ito, M. Higashihara, M. E. Kadin, L. J. Abraham, T. Watanabe, and R. Horie
AP-1 Mediated Relief of Repressive Activity of the CD30 Promoter Microsatellite in Hodgkin and Reed-Sternberg Cells
Am. J. Pathol., August 1, 2003; 163(2): 633 - 641.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. H. Kim, E. Y. Choi, Y. K. Shin, T. J. Kim, D. H. Chung, S. I. Chang, N. K. Kim, and S. H. Park
Generation of Cells With Hodgkin's and Reed-Sternberg Phenotype Through Downregulation of CD99 (Mic2)
Blood, December 1, 1998; 92(11): 4287 - 4295.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Matsumoto, H. Matsumoto, M. Seki, M. Hata, Y. Asano, S. Kanegasaki, R. L. Stevens, and M. Hirashima
Human Ecalectin, a Variant of Human Galectin-9, Is a Novel Eosinophil Chemoattractant Produced by T Lymphocytes
J. Biol. Chem., July 3, 1998; 273(27): 16976 - 16984.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.